泰林生物收盘下跌2.91%，滚动市盈率215.55倍，总市值23.08亿元

Group 1 - The core viewpoint of the news highlights that TaiLin Bio's stock price closed at 19.04 yuan, down 2.91%, with a rolling PE ratio of 215.55 times, and a total market value of 2.308 billion yuan [1] - In terms of industry comparison, the average PE ratio for the medical device industry is 48.08 times, with a median of 36.05 times, placing TaiLin Bio at the 117th position in the industry ranking [1][3] - The net inflow of main funds for TaiLin Bio on June 19 was 79,200 yuan, but over the past five days, there was a total outflow of 8.7005 million yuan [1] Group 2 - TaiLin Bio specializes in the research, production, and promotion of products related to microbiological testing and pollution control in the life sciences sector, providing high-quality solutions for various industries including biomedicine, healthcare, food and beverage, and environmental protection [2] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 66.939 million yuan, a year-on-year decrease of 16.33%, and a net profit of 3.5282 million yuan, down 39.93%, with a sales gross margin of 49.27% [2]